MacroGenics (MGNX) director receives new options and RSU awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MACROGENICS INC director Scott Thomas Jackson reported equity awards and an RSU vesting. On May 19, 2026, he received a stock option for 22,000 shares of common stock at an exercise price of $4.52 per share, expiring on May 19, 2036. He was also granted 3,750 restricted stock units (RSUs), each representing one share of common stock and scheduled to vest one year after grant or the day before the next annual meeting, if earlier.
On May 18, 2026, 3,750 RSUs vested and were exercised into 3,750 shares of common stock. Following these transactions, Jackson directly holds 14,750 shares of common stock, plus the new 3,750 RSUs and the 22,000 stock options. These are compensation-related awards and an RSU-to-share conversion, not open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,750 shares exercised/converted
Mixed
4 txns
Insider
Jackson Scott Thomas
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 3,750 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 22,000 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 3,750 | $0.00 | -- |
| Exercise | Common Stock | 3,750 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 3,750 shares (Direct, null);
Stock Option (right to buy) — 22,000 shares (Direct, null);
Common Stock — 14,750 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
Key Figures
Stock options granted: 22,000 shares at $4.52
New RSU grant: 3,750 RSUs
RSUs vested and converted: 3,750 shares
+1 more
4 metrics
Stock options granted
22,000 shares at $4.52
Option grant on May 19, 2026, exercise price $4.52, expires May 19, 2036
New RSU grant
3,750 RSUs
Granted May 19, 2026; vest one year after grant or before next annual meeting
RSUs vested and converted
3,750 shares
RSUs vested May 18, 2026 and converted into 3,750 common shares
Common shares held after transactions
14,750 shares
Direct common stock holdings following the May 18, 2026 transactions
Key Terms
Restricted Stock Unit, Stock Option, vest, exercise price, +1 more
5 terms
Restricted Stock Unit financial
"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option financial
"Stock Option (right to buy) exercisable for 22,000 underlying shares of Common Stock."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"Stock option grant with an exercise price of 4.5200 per share expiring on May 19, 2036."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Annual Meeting of Stockholders financial
"The RSUs vested on May 18, 2026, one day prior to the Issuer's 2026 Annual Meeting of Stockholders."
FAQ
What did MacroGenics (MGNX) director Scott Thomas Jackson report in this Form 4?
He reported equity-based compensation transactions, including new stock option and RSU grants and the vesting of existing RSUs into common shares. These are awards and exercises, not open-market purchases or sales, reflecting standard director compensation at MACROGENICS INC.
How many stock options were granted to the MacroGenics director in this filing?
He received a grant of stock options covering 22,000 shares of MACROGENICS INC common stock at an exercise price of $4.52 per share. These options vest in monthly 1/12th increments starting one month after the May 19, 2026 grant date and expire on May 19, 2036.
What RSU activity did MacroGenics (MGNX) disclose for director Scott Thomas Jackson?
On May 18, 2026, 3,750 restricted stock units vested and converted into 3,750 shares of common stock. On May 19, 2026, he also received a new grant of 3,750 RSUs, which will vest one year after grant or the day before the next annual meeting, if earlier.